| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 123,231 | 126,388 | 123,638 | 134,014 | | Cost of Revenue | 21,284 | 21,608 | 23,342 | 28,059 | | | Gross Profit | 101,947 | 104,780 | 100,296 | 105,955 | | | Operating Expenses | | Research Development | 12,434 | 13,166 | 12,811 | 12,321 | | Selling General and Administrative | 52,948 | 54,513 | 54,127 | 50,908 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 15,708 | 3,401 | 3,265 | 21,484 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 33,207 | 33,700 | 30,093 | 21,242 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31,601 | (6,314) | 6,150 | 7,977 | | Earnings Before Interest And Taxes | 52,458 | 27,386 | 36,243 | 29,219 | | Interest Expense | 4,674 | 985 | 9,391 | 6,956 | | Income Before Tax | 47,784 | 26,401 | 26,852 | 22,263 | | Income Tax Expense | 19,163 | 9,536 | 9,772 | 7,650 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,746 | 16,865 | 17,080 | 14,613 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,621 | 16,865 | 17,080 | 14,613 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,621 | $16,865 | $17,080 | $14,613 |
|
0.09% Nasdaq 
Income Statement
